A 3-year-old boy from rural Maharashtra presents with a 4-day history of fever, cough, coryza, and conjunctivitis. On examination, he has Koplik spots on the buccal mucosa and a maculopapular rash that started on the face 2 days ago and is now spreading downward. His vaccination status is unknown. What is the most appropriate immediate management?

Explanation

## Clinical Diagnosis and Management Rationale **Key Point:** Vitamin A supplementation is the single most important evidence-based intervention in measles management, reducing morbidity and mortality by 20–30%, particularly in children <5 years and those with malnutrition. ### Why Vitamin A in Measles? 1. **Mechanism**: Measles causes transient vitamin A depletion due to increased urinary losses and reduced absorption, leading to impaired immunity and increased risk of secondary infections and complications. 2. **WHO Recommendation**: All children with measles should receive vitamin A supplementation regardless of nutritional status. 3. **Dosing** [cite:Park 26e Ch 7]: - Children 6 months to 5 years: 200,000 IU orally on days 1 and 2; repeat on day 14 if risk of deficiency is high - Children <6 months: 50,000 IU ### Management Algorithm for Confirmed/Suspected Measles ```mermaid flowchart TD A[Suspected measles: fever + rash + Koplik spots]:::outcome --> B[Confirm diagnosis: clinical + serology/RT-PCR]:::action B --> C[Vitamin A supplementation day 1 & 2]:::action C --> D[Supportive care: fluids, antipyretics]:::action D --> E{Complications present?}:::decision E -->|Pneumonia, encephalitis| F[Hospitalize, manage complications]:::action E -->|Uncomplicated| G[Home isolation, follow-up]:::action H[Isolate 4 days from rash onset]:::action B --> H ``` **High-Yield:** Vitamin A supplementation reduces case fatality rate by 23% in hospitalized children and prevents xerophthalmia and corneal scarring. **Clinical Pearl:** Even in well-nourished children, vitamin A levels drop during measles; supplementation is not withheld based on nutritional status. ## Why Other Options Are Incorrect | Option | Rationale | |--------|----------| | Measles vaccine | Contraindicated during acute measles; vaccine is for prevention, not treatment. Post-exposure prophylaxis vaccine is given within 72 hours in susceptible contacts, not to the case. | | Ribavirin | No proven efficacy in measles; not part of standard management. Ribavirin is used in severe RSV, not measles. | | Antibiotics empirically | Not indicated unless secondary bacterial infection (e.g., pneumonia, otitis media) is documented. Measles is viral. | **Tip:** In NEET PG measles questions, always prioritize vitamin A supplementation as the first-line specific intervention after diagnosis.